Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen, UTMB Pen Liver Disease Biomarker Alliance; Shares Continue to Fall in Wake of Revenue Investigation

NEW YORK , Nov. 21 (GenomeWeb News) - Ciphergen and the University of Texas Medical Branch at Galveston plan to discover, validate, and characterize new liver disease biomarkers, the company said today.

 

Under the deal, Ciphergen will provide UTMB with its suite of proteomic solutions, including Deep Proteome, Pattern Track Process, and ProteinChip systems. UTMB will apply the technologies to its own clinical samples, Ciphergen said.

 

Ciphergen will have the first option to negotiate an exclusive license to discoveries made during the agreement and will be part of UTMB's ongoing research in liver disease, the company said.

 

Additional terms of the arrangement were not disclosed.

 

The developments come as Ciphergen's stock continues its downward spiral, falling a total of $.65, or 33.7 percent, since the company said it began investigating its second-quarter earnings on Nov. 7.

 

On Friday, Ciphergen's shares closed down 26 percent to $1.28 as the company continued its investigation.

 

As GenomeWeb News reported, Ciphergen appointed an audit committee to investigate around $500,000 in sales recorded in the second quarter. The stock price slid 7.3 percent on the initial announcement that day.

 

Since then, the share price continued to slide, accelerated by the audit committee's determination on Nov. 17 that second-quarter results should "no longer be relied upon."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.